| Dr Ali A Berry, MD | |
|
361 N Canton Center Rd, Canton, MI 48187-5096 | |
| (734) 495-1506 | |
| (734) 495-1780 |
| Full Name | Dr Ali A Berry |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 361 N Canton Center Rd, Canton, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427009729 | NPI | - | NPPES |
| DO8072 | Other | MI | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301080146 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Berry Dermatology Pc | 2466693387 | 8 |
| Dermatology Specialists Of Canton Pllc | 6507923976 | 16 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
International Nurses Day, which took place on Tuesday, was "an appropriate day ... to consider the challenges faced by health care personnel in developing countries," including those related to HIV/AIDS, Gary Cohen, board director of the U.S. Fund for UNICEF and the CDC Foundation, writes in a NorthJersey.com opinion piece.
› Verified 3 days ago
| Entity Name | Dermatology Specialists Of Canton Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003069014 PECOS PAC ID: 6507923976 Enrollment ID: O20090330000584 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
International Nurses Day, which took place on Tuesday, was "an appropriate day ... to consider the challenges faced by health care personnel in developing countries," including those related to HIV/AIDS, Gary Cohen, board director of the U.S. Fund for UNICEF and the CDC Foundation, writes in a NorthJersey.com opinion piece.
› Verified 3 days ago
| Entity Name | Dermatology & Phototherapy Center Of Brighton Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659624591 PECOS PAC ID: 7618114695 Enrollment ID: O20130510000391 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
International Nurses Day, which took place on Tuesday, was "an appropriate day ... to consider the challenges faced by health care personnel in developing countries," including those related to HIV/AIDS, Gary Cohen, board director of the U.S. Fund for UNICEF and the CDC Foundation, writes in a NorthJersey.com opinion piece.
› Verified 3 days ago
| Entity Name | Berry Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326386517 PECOS PAC ID: 2466693387 Enrollment ID: O20130718000458 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
International Nurses Day, which took place on Tuesday, was "an appropriate day ... to consider the challenges faced by health care personnel in developing countries," including those related to HIV/AIDS, Gary Cohen, board director of the U.S. Fund for UNICEF and the CDC Foundation, writes in a NorthJersey.com opinion piece.
› Verified 3 days ago
| Entity Name | Dermatology Specialists Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114652831 PECOS PAC ID: 1052780996 Enrollment ID: O20221215000658 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
International Nurses Day, which took place on Tuesday, was "an appropriate day ... to consider the challenges faced by health care personnel in developing countries," including those related to HIV/AIDS, Gary Cohen, board director of the U.S. Fund for UNICEF and the CDC Foundation, writes in a NorthJersey.com opinion piece.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ali A Berry, MD 43151 Dalcoma Dr, Clinton Twp, MI 48038-6306 Ph: (586) 286-8720 | Dr Ali A Berry, MD 361 N Canton Center Rd, Canton, MI 48187-5096 Ph: (734) 495-1506 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that it has selected Accredo Health Group, Inc., a wholly-owned subsidiary of Medco Health Solutions, Inc., to serve as the sole specialty pharmacy provider of Epoprostenol for Injection, the only epoprostenol formulated to provide up to 24-hour stability at room temperature without the use of ice packs.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.
Pharmaceutical company Pharmaxis today announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.
International Nurses Day, which took place on Tuesday, was "an appropriate day ... to consider the challenges faced by health care personnel in developing countries," including those related to HIV/AIDS, Gary Cohen, board director of the U.S. Fund for UNICEF and the CDC Foundation, writes in a NorthJersey.com opinion piece.
› Verified 3 days ago
Dr. Thomas Powell Waldinger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 285 N Lilley Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-829-2589 | |
Dr. Ann Ammond Lafond, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8584 N Canton Center Rd, Canton, MI 48187 Phone: 734-455-4917 | |
Kimberly Simons, PA Dermatology Medicare: Medicare Enrolled Practice Location: 285 N Lilley Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-495-1780 | |
Mrs. Sara Elizabeth Hayes, PA-C Dermatology Medicare: Medicare Enrolled Practice Location: 285 N Lilley Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-495-1780 | |
Dr. David Blum, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8584 N Canton Center Rd, Canton, MI 48187 Phone: 734-455-4917 | |
Andrea Elizabeth Schrieber, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 285 N Lilley Rd, Dermatology Specialists Of Canton, Canton, MI 48187 Phone: 734-495-1506 |